References
- Averill AJ, Kasarskis EJ, Segerstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:243–54.
- Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Heffernan C, Jenkinson C, Holmes T, Macleod H, Kinnear W, Oliver D, . Management of respiration in MND/ALS patients: an evidence-based review. Amyotroph Lateral Scler. 2006;7:5–15.
- Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, . Practice parameter update: the care of the patient with amyotrophic lateral sclerosis. Drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218–26.
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
- First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association, 1995.
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
- Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer. 2004;12:821–5.
- Michopoulos I, Douzenis A, Kalkavoura C, Christodoulou C, Michalopoulou P, Kalemi G, . Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry. 2008;7:4.
- Kubler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19:182–93.
- Sartorius N, Janca A. Psychiatric assessment instruments developed by the World Health Organization, Thornicroft G, Tansella M. Mental Health Outcome Measures. Berlin: Spinger; 1996. 153–77.
- Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
- Fountoulakis K, Iacovides A, Kleanthous S, Samolis S, Kaprinis SG, Sitzoglou K, . Reliability, validity and psychometric properties of the Greek translation of the Centre for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry. 2001;1:3.
- Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
- Jemos J. Beck Depression Inventory: validation in a Greek sample. Thesis. Athens, Greece: Athens University Medical School, 1984.
- Lykouras L, Oulis P, Adrachta D, Daskalopoulou E, Kalfakis N, Triantaphyllou N, . Beck Depression Inventory in the detection of depression among neurological inpatients. Psychopathology. 1998;31:213–9.
- Mystakidou K, Tsilika E, Parpa E, Smyrniotis V, Galanos A, Vlahos L. Beck Depression Inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. Eur J Cancer Care (Engl). 2007;16: 244–50.
- Ganzini L, Johnston WS, McFarland BH, Tolle SW, Lee MA. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med. 1998;339:967–73.
- Rabkin JG, Wagner GJ, del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62:271–9.
- Rabkin JG, Albert SM, del Bene ML, O'Sullivan I, Tider T, Rowland LP, . Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005;65:62–7.
- Bungener C, Piquard A, Pradat PF, Salachas F, Meininger V, Lacomblez L. Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6:221–5.
- Hammer EM, Hacker S, Hautzinger M, Meyer TD, Kubler A. Validity of the ALS-Depression-Inventory (ADI-12): a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Disord. 2008;109:213–9.
- Taylor L, Wicks P, Leigh PN, Goldstein LH. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol. 2010;17:1047–53.
- Hillemacher T, Grässel E, Tigges S, Bleich S, Neundörfer B, Kornhuber J, . Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:245–9.
- Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
- Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh PN, Goldstein LH. Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol. 2007;14:993–1001.
- Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neuron disease. J Neurol Sci. 1998;160 (Suppl 1):S53–6.
- Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997;35:785–91.